Merrill Goozner is director of the Integrity in Science project at the Center for Science in the Public Interest.
Goozner spent more than 25 years in the news business as a foreign correspondent, economics writer and investigative reporter for the Chicago Tribune and other publications. He reported from over a dozen countries while posted in Chicago, Tokyo, New York and Washington. His jobs included Chief Asia Correspondent (1991-95) and Chief Economics Correspondent (1998-2000).
His freelance writing over many years has appeared in numerous national publications including the New York Times, Washington Post, Columbia Journalism Review, The Nation, The American Prospect and the Washington Monthly. He’s won six Peter Lisagor awards; a Michigan Journalism Fellowship (1995-96); and a Kaiser Media Fellowship (2001-02). In April 2004, the University of California Press published his first book, “The $800 Million Pill: The Truth Behind the Cost of New Drugs,” an exposé of the pharmaceutical industry’s research and development practices.
Goozner left daily journalism in June 2000 to teach journalism at New York University. In December 2003, he joined as director of the Integrity in Science project, where he continues his research and writing.
Questions for Obama and McCain on health care
ASK THIS | September 12, 2008
Reporters should get down to basics with the candidates: Ask what they would do to hold down costs in the existing system and how they would promote illness prevention programs.
What can be done to lower the price of the prescription-drug benefit?
ASK THIS | March 07, 2005
Maybe it's time to start revisiting some of the provisions of the prescription-drug bill that are making it so expensive. First in an occasional series.
The NiemanWatchdog.org website is no longer being updated. Watchdog stories have a new home in Nieman Reports.